Time for optimism in amyotrophic lateral sclerosis
European Journal of Neurology · 2023-05 · 30 (5) · 1459-1464
DOI: 10.1111/ene.15738 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Neurology, online erschienen am 23.02.2023. Verfasst von Philippe Corcia und 4 weiteren Autor:innen. Beteiligte Einrichtung: CRMR SLA, CHU Tours, Tours, France. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Motor Neuron Disease. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and purpose Amyotrophic lateral sclerosis (ALS) is among the most common motor neuron diseases in adults. Nevertheless, ALS remains fatal, despite decades of research and clinical trials, which has led to negative conclusions until recently in regard to four specific treatments. It is well known that we can learn from failures, and we consider that the time has come to present positive insight on this disease.
Methods
We did a literature search using PubMed and Scopus for articles published in English from 1 January 2016, to 30 June 2022 dealing with “amyotrophic lateral sclerosis”, diagnosis, treatment, and biomarkers.
Results
A comprehensive review of the literature on diagnosis, monitoring, and treatment of this condition showed convincing evidence that we are now able to diagnose earlier as well as to better monitor and treat ALS.
Conclusions
Although ALS is often difficult to diagnose and remains incurable, there are many indications that an optimistic view of ALS management in the coming years is now realistic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CRMR SLA, CHU Tours, Tours, France.
- UMR1253 iBrain UMR, Université de Tours, INSERM, Tours, France.
- ALS Unit, IRCCS Istituti Clinici Scientifici Maugeri, Milan, Italy.
- Laboratoire de Biochimie et Biologie Moléculaire, CHRU de Tours, Tours, France.
- CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, Sorbonne Université, Paris, France.
- Département de Neurologie, Hôpital Pitié-Salpêtrière, Centre référent SLA, APHP, Paris, France.
ORCID-Profile: Philippe Corcia
Zitieren
APA
Corcia, P., Lunetta, C., Vourc'h, P., Pradat, P. F., & Blasco, H. (2023). Time for optimism in amyotrophic lateral sclerosis. European Journal of Neurology, 30(5), 1459-1464. https://doi.org/10.1111/ene.15738
Vancouver
Corcia P, Lunetta C, Vourc'h P, Pradat PF, Blasco H. Time for optimism in amyotrophic lateral sclerosis. European Journal of Neurology. 2023;30(5):1459-1464. doi:10.1111/ene.15738
BibTeX
@article{Corcia2023,
author = {Corcia, Philippe and Lunetta, Christian and Vourc'h, Patrick and Pradat, Pierre-François and Blasco, Hélène},
title = {Time for optimism in amyotrophic lateral sclerosis},
journal = {European Journal of Neurology},
year = {2023},
volume = {30},
number = {5},
pages = {1459--1464},
doi = {10.1111/ene.15738}
}
EUVIMED